2.8238
前日終値:
$2.80
開ける:
$2.8
24時間の取引高:
437.22K
Relative Volume:
0.31
時価総額:
$1.06B
収益:
$159.54M
当期純損益:
$5.06M
株価収益率:
-641.77
EPS:
-0.0044
ネットキャッシュフロー:
$26.19M
1週間 パフォーマンス:
+3.10%
1か月 パフォーマンス:
+6.60%
6か月 パフォーマンス:
+5.41%
1年 パフォーマンス:
+32.01%
Cronos Group Inc Stock (CRON) Company Profile
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
2.825 | 1.05B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.98 | 54.45B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.875 | 44.21B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.55 | 36.10B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
74.31 | 31.95B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
528.04 | 26.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-27 | 開始されました | Canaccord Genuity | Buy |
| 2022-11-02 | 開始されました | Bernstein | Mkt Perform |
| 2022-07-28 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | アップグレード | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-01-27 | アップグレード | Jefferies | Underperform → Hold |
| 2021-11-18 | 再開されました | BofA Securities | Underperform |
| 2021-04-28 | 再開されました | BofA Securities | Underperform |
| 2021-02-22 | ダウングレード | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | ダウングレード | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | アップグレード | MKM Partners | Neutral → Buy |
| 2020-03-03 | ダウングレード | Stifel | Buy → Hold |
| 2019-10-18 | アップグレード | Stifel | Hold → Buy |
| 2019-09-20 | 開始されました | MKM Partners | Neutral |
| 2019-09-05 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | 開始されました | Piper Jaffray | Overweight |
| 2019-08-09 | アップグレード | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | 開始されました | Consumer Edge Research | Equal Weight |
| 2019-06-06 | 開始されました | Stifel | Hold |
| 2019-06-05 | アップグレード | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | 開始されました | BofA/Merrill | Underperform |
| 2019-03-27 | ダウングレード | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | 開始されました | Jefferies | Underperform |
| 2019-01-18 | 開始されました | CIBC | Sector Outperform |
すべてを表示
Cronos Group Inc (CRON) 最新ニュース
What Has Cronos Group (NASDAQ:CRON) on the Earnings Calendar? - Kalkine Media
Cronos Group Inc. - Baystreet.ca
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles - Toronto Star
Cannabis Stocks: Cronos Group (TSX:CRON) Reinforces Premium Positioning - Kalkine Media
Cronos Group (TSX:CRON) Expands Global Reach Beyond TSX Venture - Kalkine Media
Top Cannabis Stocks To ResearchJuly 18th - MarketBeat
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
Cronos Group stock trades steady as cannabis earnings and cash position shape outlook - Ad-hoc-news.de
Cronos Group to hold Q2 2026 earnings call on A... - Pluang
Cronos Group - Baystreet.ca
Stocks in play: Cronos Group - Barchart.com
Cronos Group to hold Q2FY26 earnings call on August 6 - scanx.trade
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 - The Manila Times
Cronos Group management to discuss Q2 results on Aug. 6 - Stock Titan
Cannabis Stocks To Add to Your WatchlistJuly 12th - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistJuly 11th - MarketBeat
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Why Are These Top 3 TSX Stocks in the Market Spotlight? - Kalkine Media
Cronos Group Inc. stock rises Thursday, still underperforms market - MarketWatch
Cannabis Stocks To Follow TodayJuly 9th - MarketBeat
Cronos Group Inc outlines cannabis strategy as industry evolves - Ad-hoc-news.de
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Is Cronos Group (NASDAQ:CRON) Extending CanAdelaar Deal? - Kalkine Media
Cronos Group Holds Steady at $2.86 as Cannabis Sector Awaits CatalystsProtective Put - dars.gov.et
Cronos Group refines its cannabis strategy as investors weigh long-term growth prospects - Ad-hoc-news.de
Cronos Group Inc.'s Equity Buyback announced on May 8, 2025, has expired. - marketscreener.com
Cronos appoints ATB Cormark as new broker for C... - Pluang
Cronos Group changes broker for share repurchase program - Investing.com
Cronos Group changes broker for share repurchase program By Investing.com - Investing.com India
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada - GlobeNewswire
Cronos Group (CRON) adds director Darren Chester Broughton as reporting insider on Form 3 - Stock Titan
TSX Penny Stocks To Watch In June 2026 - simplywall.st
CRONCronos Group Inc Volatility & Greeks - Finviz
Cronos Group Inc. stock rises Monday, still underperforms market - MarketWatch
Price to earnings forward of Cronos Group Inc – TSX:CRON - TradingView
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
CRON strengthens global footprint: Is the cannabis stock worth buying? - MSN
CRON Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (TSX:CRON) - TradingView
Cronos Group Inc Actuals & Estimates (FWB:7CI) - TradingView
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Cronos Group (CRON) and Boston Scientific (BSX) - The Globe and Mail
7CI Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (NEO:CRON) - TradingView
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm
Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group shareholders approve board slate and auditor at annual meeting By Investing.com - Investing.com Australia
Form 8K CRONOS GROUP INC. For: 22 June By Investing.com - Investing.com India
Cronos Group Inc. (CRON) Announces 2026 Annual Meeting Results and Key SEC Filing Details - Minichart
Cronos Group Inc (CRON) 財務データ
収益
当期純利益
現金流量
EPS
Cronos Group Inc (CRON) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
大文字化:
|
ボリューム (24 時間):